Nicholas Chakiryan, M.D.

  • Assistant Professor of Urology, School of Medicine

Education and training

  • Degrees

    • B.S., 2009, Trinity College
    • M.D., 2015, SUNY Downstate College of Medicine
  • Residency

    • Urology, Oregon Health & Science University, Portland, OR, 2015-2020
  • Fellowship

    • Urologic Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, 2020-2022

Areas of interest

  • Urologic Oncology

Publications

Selected publications

  • Rosen GH, Chakiryan NH, Murray KS. Re: Jim C. Hu, Melissa Assel, Mohamad E. Allaf, et al. Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial. Eur Urol. 2024;86:61-68. Eur Urol. 2024 Jul;86(1):e14. doi: 10.1016/j.eururo.2024.03.043. Epub 2024 Apr 24. PubMed PMID: 38658308.
  • Chou WH, Chakiryan NH. Editorial Comment. J Urol. 2024 Apr;211(4):572-573. doi: 10.1097/JU.0000000000003836.01. Epub 2024 Jan 19. PubMed PMID: 38241207.
  • Grassauer J, Schmidt J, Cowan A, Gilbert SM, Chakiryan NH. Downstaging and Survival Associated with Neoadjuvant Immunotherapy Before Radical Cystectomy for Muscle-invasive Bladder Cancer. Eur Urol Oncol. 2024 Feb;7(1):139-146. doi: 10.1016/j.euo.2023.06.005. Epub 2023 Jul 14. PubMed PMID: 37453853.
  • Soupir AC, Mayes MT, … Chakiryan NH, … Manley BJ. Increased spatial coupling of integrin and collagen IV in the immunoresistant clear cell renal cell carcinoma tumor microenvironment. bioRxiv (Preprint). 2023;
  • Hugar LA, Peak TC, … Chakiryan NH, … Spiess PE. Predicting limited survival following inguinal lymph node dissection in penile cancer. Urology. 2023;
  • Chakiryan NH, Gore LR, … Gilbert SM. Survival outcomes associated with cytoreductive nephrectomy in patients with metastatic clear cell renal cell carcinoma. JAMA Network Open. 2022;
  • Chang A, Chakiryan NH, … Manley BJ. Novel splice site variants as promising prognostic biomarkers in clear cell renal cell carcinoma. European Urology.2022;
  • Rappold P, Vuong L, …Chakiryan NH, … Hakimi AA. A targetable myeloid inflammatory state governs recurrence in clear cell renal cell carcinoma. Cancer Discovery. 2022;
  • Ferrall-Fairbanks MC, Chakiryan NH, … Altrock PM. Tumor infiltrating lymphocyte CDR3 diversity in clear cell renal cell carcinoma. Cancer Research. 2022;